NCT06299189 A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
| NCT ID | NCT06299189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Haukeland University Hospital |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-01-01 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to explore and evaluate the use and utility of a guided Internet-delivered psychological treatment for adults with ADHD with a combined focus on: i) Evaluating the impact of potential predictors to treatment adherence, treatment response, treatment use and utilty. ii) Evaluating the feasibility, clinical benefits and implementation process of the treatment in routine outpatient care. iii) Evaluate the cost-effectiveness of the treatment program.
Eligibility Criteria
Inclusion criteria: \| * Age ≥18 * A self-reported diagnosis of ADHD * Access to and ability to use a computer, smartphone and the Internet. * Speaks, writes and reads Norwegian Exclusion criteria: * In need of other psychological treatment for mental health illness such as borderline or personality disorder, bipolar disorder, substance abuse or psychosis. * Ongoing psychological treatment for ADHD or other psychiatric illnesses.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06299189 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06299189 currently recruiting?
Yes, NCT06299189 is actively recruiting participants. Contact the research team at aleksander.gulla.heltne@helse-bergen.no for enrollment information.
Where is the NCT06299189 trial being conducted?
This trial is being conducted at Bergen, Norway.
Who is sponsoring the NCT06299189 clinical trial?
NCT06299189 is sponsored by Haukeland University Hospital. The trial plans to enroll 200 participants.